Itsgiafox Nude - Flywheelsites News
Evaluate orserdu®, a treatment option for esr1-mutated, er+/her2-advanced or metastatic breast cancer following disease progression on endocrine therapy. Rugo h, tolaney sm, chan n, et al. Elacestrant in combination with everolimus or abemaciclib in patients with er+/her2- locally advanced or metastatic breast cancer (mbc):
In the uk, korserdu® (elacestrant) monotherapy is indicated for the treatment of postmenopausal women, and men, with oestrogen receptor (er)-positive, human epidermal growth factor receptor 2 …
